Sands Capital Management LLC Has Increased Incyte Corp (INCY) Stake by $130.93 Million

June 14, 2018 - By Vivian Currie

Incyte Corporation (NASDAQ:INCY) LogoInvestors sentiment increased to 1.22 in 2018 Q1. Its up 0.16, from 1.06 in 2017Q4. It improved, as 45 investors sold INCY shares while 131 reduced holdings. 57 funds opened positions while 157 raised stakes. 190.28 million shares or 0.76% less from 191.73 million shares in 2017Q4 were reported. Kistler reported 0.01% stake. Natl Pension Serv reported 192,132 shares. Parametric Port Associate Limited Liability Corp has invested 0.03% in Incyte Corporation (NASDAQ:INCY). 295 are held by Reilly Fincl Advsrs Ltd Liability Co. Sectoral Asset Mgmt holds 0.72% or 79,245 shares in its portfolio. Mirae Asset Invs Ltd stated it has 0.02% of its portfolio in Incyte Corporation (NASDAQ:INCY). Eqis Cap Mngmt reported 0.08% of its portfolio in Incyte Corporation (NASDAQ:INCY). Hap Trading Ltd Llc accumulated 163,116 shares. Sumitomo Mitsui reported 507,195 shares. Pitcairn holds 5,131 shares or 0.05% of its portfolio. Cadian Management Lp invested 0.07% of its portfolio in Incyte Corporation (NASDAQ:INCY). Gabelli And Advisers, New York-based fund reported 16,900 shares. Tocqueville Asset Mngmt Lp reported 70,025 shares or 0.07% of all its holdings. Massachusetts-based Frontier Lc has invested 0.25% in Incyte Corporation (NASDAQ:INCY). Advantus Cap holds 0.04% in Incyte Corporation (NASDAQ:INCY) or 17,877 shares.

Since January 5, 2018, it had 1 buying transaction, and 4 sales for $5.08 million activity. 6,760 Incyte Corporation (NASDAQ:INCY) shares with value of $668,361 were sold by GRYSKA DAVID W. 15,000 shares were bought by Hoppenot Herve, worth $914,100. The insider Huber Reid M sold $167,507.

Sands Capital Management Llc increased its stake in Incyte Corp (INCY) by 19.26% based on its latest 2018Q1 regulatory filing with the SEC. Sands Capital Management Llc bought 1.58 million shares as the company’s stock declined 21.82% with the market. The institutional investor held 9.77M shares of the commercial physical & biological resarch company at the end of 2018Q1, valued at $814.03M, up from 8.19 million at the end of the previous reported quarter. Sands Capital Management Llc who had been investing in Incyte Corp for a number of months, seems to be bullish on the $15.63 billion market cap company. The stock increased 4.54% or $3.2 during the last trading session, reaching $73.74. About 2.37 million shares traded. Incyte Corporation (NASDAQ:INCY) has declined 50.56% since June 14, 2017 and is downtrending. It has underperformed by 63.13% the S&P500.

Sands Capital Management Llc, which manages about $42.07 billion and $33.81B US Long portfolio, decreased its stake in Activision Blizzard Inc (NASDAQ:ATVI) by 354,747 shares to 5.99 million shares, valued at $403.91 million in 2018Q1, according to the filing. It also reduced its holding in Medidata Solutions Inc (NASDAQ:MDSO) by 230,350 shares in the quarter, leaving it with 3.32M shares, and cut its stake in Regeneron Pharmaceuticals (NASDAQ:REGN).

More important recent Incyte Corporation (NASDAQ:INCY) news were published by: Seekingalpha.com which released: “Best And Worst Performing Nasdaq 100 Stocks Of 2018” on May 25, 2018, also Nasdaq.com published article titled: “3 Biotechs With Huge FDA Decisions in June”, Streetinsider.com published: “Incyte (INCY) Strength Tied to AbbVie’s (ABBV) M&A Comment – Bloomberg” on June 14, 2018. More interesting news about Incyte Corporation (NASDAQ:INCY) was released by: Seekingalpha.com and their article: “Premarket analyst action – healthcare” with publication date: June 11, 2018.

Incyte Corporation (NASDAQ:INCY) Ratings Coverage

Among 16 analysts covering Incyte (NASDAQ:INCY), 12 have Buy rating, 0 Sell and 4 Hold. Therefore 75% are positive. Incyte had 21 analyst reports since January 2, 2018 according to SRatingsIntel. The stock of Incyte Corporation (NASDAQ:INCY) has “Overweight” rating given on Tuesday, April 24 by JP Morgan. The firm earned “Overweight” rating on Monday, April 9 by JP Morgan. Credit Suisse maintained Incyte Corporation (NASDAQ:INCY) rating on Monday, April 9. Credit Suisse has “Outperform” rating and $78 target. The stock of Incyte Corporation (NASDAQ:INCY) earned “Buy” rating by RBC Capital Markets on Thursday, February 15. Oppenheimer maintained Incyte Corporation (NASDAQ:INCY) rating on Tuesday, May 1. Oppenheimer has “Hold” rating and $6500 target. The stock of Incyte Corporation (NASDAQ:INCY) has “Buy” rating given on Wednesday, April 4 by RBC Capital Markets. SunTrust maintained Incyte Corporation (NASDAQ:INCY) rating on Monday, April 23. SunTrust has “Buy” rating and $7500 target. The rating was reinitiated by PiperJaffray with “Overweight” on Thursday, May 31. The stock of Incyte Corporation (NASDAQ:INCY) has “Buy” rating given on Thursday, April 12 by UBS. The rating was upgraded by RBC Capital Markets on Tuesday, January 2 to “Outperform”.

Incyte Corporation (NASDAQ:INCY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: